Recruiting NA INTERVENTIONAL 2-arm NCT04084938

Artery Embolization vs Operation of Benign Prostate Hyperplasia (NORTAPE)

Prostatic Artery Embolization vs Transurethral Resection of the Prostate or Open Prostatectomy in Patients With Symptomatic Benign Prostatic Hyperplasia

Sponsor: Oslo University Hospital

Conditions Benign Prostatic Hyperplasia Embolization Therapeutic Post-Op Complication Transurethral Resection of Prostate Syndrome

Interventions Prostate operation or prostate artery embolization

Updated 6 times since 2019 Last updated: Dec 26, 2023 Started: Sep 1, 2019 Primary completion: Dec 31, 2024 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Benign Prostatic Hyperplasia and Embolization Therapeutic and is currently actively recruiting participants. Oslo University Hospital leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA
Jan 2021 — Jan 2024 [monthly]

Recruiting NA
Dec 2019 — Jan 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Oct 2019 — Dec 2019 [monthly]

Recruiting NA

First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway